Benzo[c][1,2,5]thiadiazole-4-carbonitrile

Catalog No.: 
ACMCEN814
CAS No.: 
54554-45-9
Molecular Formula: 
C7H3N3S
Molecular Weight: 
161.19
Benzo[c][1,2,5]thiadiazole-4-carbonitrile structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$190.00InquiryInquiry
1g95%$608.00In stockInquiry
5g95%$2979.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameBenzo[c][1,2,5]thiadiazole-4-carbonitrile
IUPAC Namebenzo[c][1,2,5]thiadiazole-4-carbonitrile
Molecular FormulaC7H3N3S
Molecular Weight161.19
SMILESN#CC1=CC=CC2=NSN=C21
InChI KeyIYIREDJNNOUDAP-UHFFFAOYSA-N
SynonymBenzo[c][1,2,5]thiadiazole-4-carbonitrile;2,1,3-Benzothiadiazole-4-carbonitrile
CAS No.54554-45-9

Safety Data

Pictogram
Toxic
Signal Word
Danger
Hazard Statement(s)
H301-H311-H331
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P310-P330-P361-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACMCEN814 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCLYH540 route compound structure diagram
    ACCLYH54022034-13-5In Stock
  2. Plus
  3. ACFXPJ467 route compound structure diagram
    ACFXPJ46713963-58-1In Stock
  4. Then
  5. ACMCEN814 route product structure diagram
    ACMCEN81454554-45-9In Stock
Inquiry

2. ACMCEN814 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACVAEM051 route compound structure diagram
    ACVAEM0511823869-65-3In Stock
  2. Then
  3. ACMCEN814 route product structure diagram
    ACMCEN81454554-45-9In Stock
Inquiry

3. ACMCEN814 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCLYH540 route compound structure diagram
    ACCLYH54022034-13-5In Stock
  2. Plus
  3. ACFXPJ467 route compound structure diagram
    ACFXPJ46713963-58-1In Stock
  4. Then
  5. ACMCEN814 route product structure diagram
    ACMCEN81454554-45-9In Stock
Inquiry

Comments (0)